Purchase Order 75N91021P00302
- Not listed
- Bio-Rad Laboratories, Inc. Life Science Group Division was awarded an $11,619.77 firm fixed price purchase order by the Department of Health and Human Services National Institutes of Health National Cancer Institute on April 1, 2019. The contract has a completion date of January 31, 2024 and no set-aside designation was used. This purchase order is associated with Bio-Rad Laboratories' five-year, $1 billion blanket purchase agreement with the Department of Health and Human Services National...
- This $16,238.00 firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development, a civilian agency within the Department of Health and Human Services, to Bio-Rad Laboratories, Inc.'s Life Science Group Division. The award does not have a set-aside designation. Bio-Rad Laboratories, Inc. is a leading global manufacturer of products for life science research and clinical diagnostics, including PCR systems, reagents, and other laboratory equipment and...
- Bio-Rad Laboratories, Inc.'s Life Science Group Division has been awarded a $30,298.80 firm fixed-price purchase order by the National Institutes of Health Clinical Center, with an ultimate completion date of January 22, 2027. The contract, which was not subject to small business set-aside designation, was awarded on January 23, 2026, and will be performed at Bio-Rad's facility in Hercules, California. As a global leader in life science research and clinical diagnostics, Bio-Rad will supply...
- This is a $35,720.00 firm fixed-price purchase order awarded by the Office of Logistics and Acquisition Operations within the Department of Health and Human Services' National Institutes of Health (NIH) to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the global life sciences company Bio-Rad Laboratories, Inc. The contract is for the provision of imaging equipment, medical/dental/veterinary supplies, and associated warehouse equipment to support NIH's research and...
- Bio-Rad Laboratories, Inc. was awarded a firm fixed-price purchase order valued at $34,575.59 by the National Institutes of Health Office of Logistics and Acquisition Operations on May 1, 2026, with an ultimate completion date of August 1, 2026. This contract award carries no small business set-aside designation. The award represents a task order placed against Bio-Rad's existing $10 million Blanket Purchase Agreement with NIH, which became effective December 18, 2023, and remains valid...
- This federal contract award to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the global life sciences company Bio-Rad Laboratories, Inc., is for the provision of various products and services to support biomedical research and testing. The $10,212.75 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract does not have a set-aside designation. Bio-Rad Laboratories, Inc. holds a major $1...
- This is a firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the U.S. Department of Health and Human Services, to Bio-Rad Laboratories, Inc. for $26,172.54. The contract has an ultimate completion date of August 20, 2020 and does not have a set-aside designation. Bio-Rad Laboratories, Inc. is a global leader in developing and manufacturing products for life science research and clinical diagnostics. The company...
- This federal contract award to Bio-Rad Laboratories, Inc. (a large, for-profit manufacturer of life science research and diagnostic products) for $16,705.34 was issued by the National Human Genome Research Institute, a component of the National Institutes of Health. The contract, a firm fixed-price purchase order, provides for the delivery of unspecified products or services, as there was no set-aside designation. Bio-Rad Laboratories holds a $1 billion Blanket Purchase Agreement with the NIH to...
- This contract was awarded by the National Institutes of Health (NIH) to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the publicly traded life sciences company Bio-Rad Laboratories, Inc. The $22,853.96 firm-fixed-price purchase order does not have a set-aside designation. It provides for the delivery of various biological research products and associated maintenance services to the NIH. Bio-Rad Laboratories, Inc. holds a $1 billion Blanket Purchase Agreement with the...
- This federal contract award is for BIO-RAD LABORATORIES:1110109, a $148,783.32 firm-fixed-price purchase order issued by the National Institutes of Health (NIH) Clinical Center. The contract does not have a set-aside designation. Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the larger Bio-Rad Laboratories, Inc. corporation, is the prime contractor. The contract is for the delivery of various laboratory instruments, reagents, and consumables related to biomedical...
This is a $346,770.62 firm fixed price purchase order awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc.'s Life Science Group Division. The contract is for the Laboratory of Receptor Biology and Gene Expression (LRGBE) to elucidate the mechanisms involved in the regulation of genetic expression in eukaryotic cells and identify the genes and regulatory processes involved in modulated states of expression. The contract has a performance period through July 31, 2026 and does not involve any set-aside designations. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostics products, and the company has established numerous federal Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) with agencies like NIH, USDA, and IHS to efficiently provide a variety of laboratory equipment, reagents, and maintenance services in support of government research programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Exercise an Option | $28.9k | 7/29/24 | |
| P00003 | Other Administrative Action | $64.3k | 7/25/23 | |
| P00002 | Exercise an Option | $70.6k | 4/25/22 | |
| P00001 | Other Administrative Action | $0 | 10/20/21 | |
| Not listed | Not listed | $70.6k | 4/14/21 |